Paid Clinical Trials Newark

Discover 259 paid clinical trials in Newark, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 259

A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Recruiting

PHASE3

Sponsor:

Boston Children's Hospital

Location:

Wilmington DE, Philadelphia PA, Washington DC, New York NYshow 43 more

Code:

NCT05600426

Conditions

Severe Aplastic Anemia

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

cyclosporine

Matched Unrelated Donor Hematopoetic Stem Cell Transplant

horse anti-thymocyte globulin (ATG)

rabbit anti-thymocyte globulin (ATG)

Methotrexate

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Newark DE, Elkton MD, Wilmington DE, Chadds Ford PAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Testing the Addition of Immunotherapy Before Surgery for Patients with Sarcomatoid MesotheliomaTesting the Addition of Immunotherapy Before Surgery for Patients with Sarcomatoid Mesothelioma

Recruiting

PHASE2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Newark DE, Elkton MD, Wilmington DE, Chadds Ford PAshow 65 more

Code:

NCT05647265

Conditions

Pleural Biphasic Mesothelioma

Pleural Sarcomatoid Mesothelioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Ipilimumab

Surgical Procedure

Computed Tomography

Magnetic Resonance Imaging

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary FibrosisA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Newark DE, Wynnewood PA, Philadelphia PA, Towson MDshow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

National Collaborative to Improve Care of Children With Complex Congenital Heart DiseaseNational Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Wilmington DE, Philadelphia PA, Baltimore MD, Harrisburg PAshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

Cerebral Palsy Hip Outcomes Project - International Multi-centre StudyCerebral Palsy Hip Outcomes Project - International Multi-centre Study

Recruiting

Sponsor:

Holland Bloorview Kids Rehabilitation Hospital

Location:

Wilmington DE, New York NY, Boston MA, Torontoshow 7 more

Code:

NCT01987882

Conditions

Cerebral Palsy

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab Vs Pembrolizumab in First-line Treatment of Head and Neck CancerA Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab Vs Pembrolizumab in First-line Treatment of Head and Neck Cancer

Recruiting

PHASE3

Sponsor:

Merus N.V.

Location:

Newark DE, Philadelphia PA, Norfolk VA, Blacksburg VAshow 17 more

Code:

NCT06525220

Conditions

Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Petosemtamab

Pembrolizumab

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting

PHASE2

Sponsor:

Allogene Therapeutics

Location:

Newark DE, East Brunswick NJ, New Brunswick NJ, Fairfax VAshow 27 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide

Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

Oxytocin Rest to Reduce Cesarean DeliveryOxytocin Rest to Reduce Cesarean Delivery

Recruiting

Sponsor:

Christiana Care Health Services

Location:

Newark DE

Code:

NCT06268431

Conditions

Prolonged Labor

Failed Induction

Labor Dystocia

Eligibility Criteria

Sex: Female

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Oxytocin rest

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin LymphomaA Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Recruiting

Sponsor:

Children's Oncology Group

Location:

Wilmington DE, Philadelphia PA, Hackensack NJ, Albany NYshow 19 more

Code:

NCT05705531

Conditions

Cardiovascular Disorder

Clonal Hematopoiesis

Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 7 - 40

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Electronic Health Record Review

Magnetic Resonance Imaging

Survey Administration